Nāu te kākahu i whatu. He tāniko tāku.
Kia ora rā, tēnei te tono ki a koe.
Welcome to the RAUORA study.
RAUORA - a study about helping you to quit smoking. RAUORA is being undertaken predominantly in the Lakes District Health Board region of Aotearoa New Zealand and over time will be extended to surrounding areas.
Many smokers regret having started smoking and want to quit but giving up smoking can be hard. The RAUORA study is comparing two similar medicines (Tabex and Champix) to see how good they are at helping people to stop smoking cigarettes.
The medicine ‘Tabex’ has been used for more than 40 years in Europe to help people quit smoking. Tabex contains cytisine, which is obtained from a plant called the Golden Rain. Cytisine is also found in several New Zealand plants, including the Kowhai. Tabex is not currently approved or registered in New Zealand as a smoking cessation treatment, so it is not easily available.
The best treatment available in New Zealand to help you quit smoking is a medicine called ‘Champix’, also called varenicline. Varenicline is not obtained from a plant, but has been developed from cytisine.
Tabex and Champix help people quit smoking in the same way. Both Tabex and Champix help make withdrawal feelings less severe. Tabex and Champix reduce the feeling of reward you get from smoking. In other words, you won’t enjoy smoking so much.
What we don’t know about Tabex and Champix is whether one medicine is better than the other, or whether they are equally good at helping people stop smoking. This is why we are undertaking The RAUORA study.
If you think you’d like to take part in our trial click here to read our participant information sheet. This sheet will tell you more about the trial, who can and can’t be involved, and what it involves.
If you’ve read the participant information sheet and are keen to express interest in joining the trial, once it starts recruiting, please contact us